| 000 | 01787 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514045343.0 | ||
| 264 | 0 | _c20021018 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/S0022-5347(05)64454-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThalmann, George N | |
| 245 | 0 | 0 |
_aLong-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cOct 2002 |
||
| 300 |
_a1381-5 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma in Situ _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aNephrostomy, Percutaneous |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUreter _xpathology |
| 650 | 0 | 4 |
_aUreteral Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aUrinary Diversion |
| 700 | 1 | _aMarkwalder, Regula | |
| 700 | 1 | _aWalter, Bernhard | |
| 700 | 1 | _aStuder, Urs E | |
| 773 | 0 |
_tThe Journal of urology _gvol. 168 _gno. 4 Pt 1 _gp. 1381-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0022-5347(05)64454-0 _zAvailable from publisher's website |
| 999 |
_c12165035 _d12165035 |
||